- Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life and Cardiovacular Risk2007 | First Faculty of Medicine
- Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life and Cardiovacular Risk2007 | Faculty of Medicine in Hradec Králové
- Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data +12015 | First Faculty of Medicine, Second Faculty of Medicine
- NAFLD from a hepatologist's point of view2021 | Second Faculty of Medicine
- How do we determine absolute cardiovascular risk. Do we need more (new) risk factors?2006 | First Faculty of Medicine
- Acetylsalicylic acid in primary prevention - new data2019 | Publication without faculty affiliation